MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease

por Nath, Samir R., Lieberman, Matthew L., Yu, Zhigang, Marchioretti, Caterina, Jones, Samuel T., Danby, Emily C. E., Van Pelt, Kate M., Sorarù, Gianni, Robins, Diane M., Bates, Gillian P., Pennuto, Maria, Lieberman, Andrew P.
Publicado 2020